Game to Launch on Wednesday, April 25th LOS ANGELES-Thursday, April 5th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- Jam City: Who: Jam City, a Los Angeles based mobile games studio, in partnership with Warner Bros. Interactive Entertainment. What: Actors from the Harry Potter films will provide voiceover work for Jam City’s Harry Potter: Hogwarts Mystery. A full list of actors providing voice work for the game include: Dame Maggie Smith (Professor McGonagall) Michael Gambon (Professor Dumbledore) Warwick Davis (Professor Flitwick) Sally Mortemore (Madam Irma Pince) Gemma Jones (Madam Pomfrey) Zoe Wanamaker (Madam Hooch) Global launch date for Harry Potter: Hogwarts Mystery confirmed to be Wednesday, April 25th on iOS and Android. Where: Los Angeles, California Quotes: “If I could attend Hogwarts as a student, I would be most excited to attend the potions class taught by Severus because it is the most exotic,” said Dame Maggie Smith, voice of Professor McGonagall. "Our goal with Harr ... Read more »

• Boehringer Ingelheim and OSE Immunotherapeutics enter into a global license and collaboration agreement in immuno-oncology to develop OSE-172, a novel checkpoint inhibitor antibody targeting myeloid lineage cells • Assuming all milestones are met, OSE stands to receive more than €1.1 billion • OSE-172, an anti-SIRP-alpha monoclonal antibody, is currently in late stage preclinical development with potential in various cancers • With this collaboration, Boehringer Ingelheim strengthens a core pillar of its cancer immunology and immune modulation strategy focusing on novel approaches to treat cancer INGELHEIM, Germany & NANTES, France-Thursday, April 5th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, today announced a collaboration and exclusive worldwide collaboration and license agreement to jointly develop OSE-172, a SIRP-alpha antagonist targeting myeloid ... Read more »

BANGALORE, India-Monday, April 9th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- L&T Technology Services Limited (NSE: LTTS), a leading global pure-play engineering R&D services company, today announced that it has signed an agreement with ExxonMobil Exploration Company, valued at more than $20 million in the first year. LTTS’ geospatial and digital expertise will enable rapid conversion of historical Geoscience content into the digital domain by leveraging sophisticated automation utilities. This will provide geoscientists with improved data availability, enhancing the speed and efficiency of analysis and evaluation. LTTS will work in collaboration with group company Larsen & Toubro Infotech (LTI) on this engagement. This deal re-affirms LTTS’ technology investment strategy for its flagship customers and ensures its position as a leading partner among top ER&D service providers by capitalizing on the rapidly changing digital shifts in the Oil and Gas industry. “Combining our Hydrocarbon ... Read more »

SAINT-PREX, Switzerland & ROSEVILLE, Minn.-Thursday, April 5th 2018 [ AETOS Wire ] Rebiotix’s RBX2660 is a non-antibiotic treatment in Phase 3 development for the prevention of recurrent Clostridium difficile infection (CDI) and has the potential to be the world’s first approved human microbiome product CDI is one of the most common healthcare-associated infections in the US, affecting more than 500,000 people and causing approximately 29,000 deaths each year.1 Ferring’s global capabilities ensure broader patient access to any future approved human microbiome treatments derived from Rebiotix’s Microbiota Restoration Therapy™ (MRT™) drug platform (BUSINESS WIRE) -- Ferring Pharmaceuticals* and Rebiotix Inc. today announce that they have agreed to the acquisition of Rebiotix by Ferring. This acquisition brings together two innovative healthcare companies that share a common commitment to exploring and understanding the human microbiome to develop new solutions for patients. This pr ... Read more »

With UAE’s world-class healthcare infrastructure, expertise, and services, Emirates Hospital Jumeirah is well-positioned to match the highest international standards. Dubai, United Arab Emirates-Sunday, April 8th 2018 [ AETOS Wire ] Speaking on World Health Day, Dr Yehia El Gabbani, Hospital Director of Emirates Hospital-Jumeirah, said the UAE healthcare market’s innovative progress make it the leading healthcare destination in the MENA region. The country has seen a surge in new specialised services and treatments for residents and innovative products such as surgical robots, augmented reality systems, and artificial intelligence. The UAE healthcare market, which is projected to reach $19.5 billion (Dh71.56 billion) by 2020, is a leading healthcare destination in the GCC region. The UAE is also world's fastest growing medical tourism hub, with total health expenditure allocation jumping from the current $23 billion to $28 billion by 2021. With UAE’s world-class healthcare infrastr ... Read more »

LUXEMBOURG -Wednesday, April 4th 2018 [ AETOS Wire ] (BUSINESS WIRE)-- The number of video households served by SES has continued to increase, reaching 351 million TV homes in 2017 according to SES’s annual market research, Satellite Monitor. This substantial technical reach compared with 325 million households in 2016 means that SES is now delivering video content to more than 1 billion global viewers. SES’s increased technical reach reflects the expansion of the survey with the addition of new countries (Ethiopia, Tanzania, Uganda and Turkey) and the wider reach of Yahlive, namely in the Maghreb countries, together accounting for 17 million more SES TV homes. On a like-for-like basis, the technical reach grew by 9 million SES TV homes, mainly in Nigeria, Ghana and the Middle East. Out of its 351 million TV homes, SES directly reaches 145 million, and indirectly serves another 147 million cable homes, 40 million IPTV homes, and 18 million terrestrial homes. The Satellite Monitor s ... Read more »